Anti-Cancer Immune Response - PhotosoftTM technology

  1. 6,189 Posts.
    lightbulb Created with Sketch. 106
    Hi Guys,

    Thought IVX needs a positive thread and an update, so we are looking at Human trials this year. Could be worth dollar cost averaging at these prices.

    About Photodynamic Therapy (PDT)Invion is developing PhotosoftTM technology as a novel next generation Photodynamic Therapy (PDT). PDT uses non-toxic photosensitisers and light to selectively kill cancer cells and promote an anti-cancer immune response. Less invasive than surgery and with minimal side effects, PDT offers an alternative treatment option aimed at achieving complete tumour regression and long-lasting remission. .
    R&D activities during the quarter Invion is focused on the development of the Photosoft™ technology for the treatment of cancers and infectious diseases and atherosclerosis (AID). During the quarter, the Company continued to work with its research partners to lay the groundwork for clinical trials in at least two types of cancers – skin and anogenital. These trials are expected to commence before the end of this calendar year.

    www.inviongroup.com.

    GLA

    DYOR
    Last edited by cashngrab: 27/06/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.6¢
Change
0.000(0.00%)
Mkt cap ! $8.199M
Open High Low Value Volume
9.7¢ 9.7¢ 9.6¢ $1.669K 17.31K

Buyers (Bids)

No. Vol. Price($)
1 75887 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 344080 4
View Market Depth
Last trade - 13.32pm 30/07/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.